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Abstract
Background: The HIV/AIDS epidemic in Kenya is a major public-health problem. Estimating the prevalence of HIV in
pregnant women provides essential information for an effective implementation of HIV/AIDS control measures and
monitoring of HIV spread within a country. The objective of this study was to determine the prevalence of HIV infection,
risk factors for HIV/AIDS and immunologic (lymphocyte profile) characteristics among pregnant women attending
antenatal clinics in three district hospitals in North-Rift, Kenya.
Methods: Blood samples were collected from pregnant women attending antenatal clinics in three district hospitals
(Kitale, Kapsabet and Nandi Hills) after informed consent and pre-test counseling. The samples were tested for HIV
antibodies as per the guidelines laid down by Ministry of Health, Kenya. A structured pretested questionnaire was used
to obtain demographic data. Lymphocyte subset counts were quantified by standard flow cytometry.
Results: Of the 4638 pregnant women tested, 309 (6.7%) were HIV seropositive. The majority (85.1%) of the antenatal
attendees did not know their HIV status prior to visiting the clinic for antenatal care. The highest proportion of HIV
infected women was in the age group 21–25 years (35.5%). The 31–35 age group had the highest (8.5%) HIV prevalence,
while women aged more than 35 years had the lowest (2.5%).
Women in a polygamous relationship were significantly more likely to be HIV infected as compared to those in a
monogamous relationship (p = 0.000). The highest HIV prevalence (6.3%) was recorded among antenatal attendees who
had attended secondary schools followed by those with primary and tertiary level of education (6% and 5% respectively).
However, there was no significant relationship between HIV seropositivity and the level of education (p = 0.653 and p =
0.469 for secondary and tertiary respectively). The mean CD4 count was 466 cells/mm3 (9–2000 cells/mm3). Those that
had less than 200 cells/mm3 accounted for 14% and only nine were on antiretroviral therapy.
Conclusion: Seroprevalence of HIV was found to be consistent with the reports from the national HIV sentinel surveys.
Enumeration of T-lymphocyte (CD4/8) should be carried out routinely in the antenatal clinics for proper timing of
initiation of antiretroviral therapy among HIV infected pregnant women.
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Background
HIV/AIDS is the major health priority in Kenya. Sentinel
surveillance in antenatal women has been used to project
national HIV seroprevalence in Kenya since 1990 [1]. The
system operates within antenatal clinics situated in urban
and peri-urban or rural sites around the country, that offer
care to women during pregnancy. Each year, pregnant
women in each site are anonymously tested for HIV.
The estimate for prevalence in Kenya at the end of 2003
was 6.7%, following refinement of the models used for
calculations to include data from household surveys
rather than just sentinel surveillance data [2]. In the pre-
liminary results of the 2007 Kenya AIDS Indicator Survey
(KIAS), the overall prevalence rate for the country was esti-
mated to be 7.8% for Kenyans ages 15–49 and 7.4% for
ages 15–64. It is estimated that 2.2 million Kenyans are
now living with HIV infection, but few know whether they
are infected or show outward symptoms of the disease.
This study was part of a major protocol determining the
prevalence of HIV nevirapine resistant genotypes and
their effects on mother-to-child transmission among ante-
natal clinic attendees in three district hospitals in North
Rift Valley Province of Kenya. The North Rift region was
chosen because it lacked documented risk factors for HIV
transmission. Kitale hospital is an existing sentinel site
under the National HIV/AIDS Control Programme, while
Nandi hills and Kapsabet hospitals were included as new
sites for the study. The latter hospitals were included since
no information on the HIV prevalence was available. Gen-
erating local epidemiological and socio-demographic
data of HIV infection is of critical importance in planning
of interventions in the area.
Methods
Setting
The study was carried out from April 2005 to September
2006 at Kitale, Kapsabet and Nandi hills district hospitals.
Participants
All pregnant women attending the antenatal clinic for the
first time during the current pregnancy were included.
Voluntary counseling and testing (VCT) for HIV among
pregnant women has been integrated into maternal child
health (MCH) facilities in all the public hospitals as part
of prevention of mother to child transmission (PMTCT)
of HIV. All the pregnant women attending the antenatal
clinics were sensitized with basic knowledge on HIV/
AIDS. The importance of knowing their HIV status and the
availability of measures to reduce the risk of mother to
child transmission were explained in greater detail. The
objectives of the study were explained and informed con-
sent was obtained by signature or finger print from ANC
attendees. Enrolment and counseling were done in all the
three hospitals.
This study was approved by the Kenya Medical Research
Institute Scientific Steering Committee and Ethical Review
Board (Ref. SSC No. 822). The study was conducted
according to the national and international regulations
governing the use of human subjects in biomedical
research.
Data collection tool
A pre-tested standard structured questionnaire was used
for interview. The information sought included basic
demographic data.
Specimen
Routine investigations in the antenatal clinic necessitate
blood withdrawal for HIV testing. A small amount of this
blood was used also for enumeration of T-lymphocytes,
which is not done routinely. Five milliliters venous blood
sample was collected in a sterile vacutainer tube contain-
ing EDTA as anticoagulant from all pregnant women.
Serology
HIV antibodies were tested by rapid tests as per the guide-
lines laid down by the Ministry of Health, Kenya. Rapid
parallel testing was carried out using Determine™ HIV-1/2
(Abbott Diagnostic Division) and Uni-Gold™ HIV (Trinity
Biotech) test kits. In case of discrepancy, Bioline HIV 1/2
3.0 (Standard Diagnostics) was used as a tiebreaker.
Lymphocyte subset counting
Lymphocyte subset counts were performed by standard
flow cytometry. The details of the procedure were per-
formed in accordance with the manufacturer's instruc-
tions (Tritest; Becton-Dickinson, Franklin Lakes, NJ).
Briefly, 50 μl of whole blood with EDTA were incubated
with three-color fluorochrome-labeled monoclonal anti-
bodies. After lysis and incubation, flow cytometric analy-
sis was performed on a FACSCalibur cytometer using an
automatic acquisition and analysis program (Multiset;
Becton-Dickinson). The absolute CD4 T cell counts were
recorded and used in this study.
Statistical analysis
Data were entered using Microsoft Access (Microsoft Cor-
poration, Redmond, Washington) and statistical analyses
performed using EPI INFO 3.2.2 statistical package. We
present odds ratios (OR), and 95% confidence interval
(CI) for factors associated with HIV infection.
Results
Data were collected and analyzed from a total of 4,638
pregnant women attending antenatal care in Kitale, Kaps-
abet and Nandi Hills district hospitals. Out of theseBMC International Health and Human Rights 2009, 9:10 http://www.biomedcentral.com/1472-698X/9/10
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26.8% were from Kitale, 31.2% from Kapsabet and 41.9%
from South Nandi Hills. Table 1 presents the socio-demo-
graphic characteristics of the pregnant women. Analysis of
age, educational status and marital status, were done for
the clients with information recorded in questionnaire.
The ages for 4,595 pregnant women were recorded and
categorized into < 21, 21–25, 26–30, 31–35 and > 35
years. The majority (34.8%) were aged 21–25 years while
4.4% were aged above 35 years. Most (69.4%) of the
respondents had primary school education with 3.8%
having tertiary education. Of the 4,550 ANC attendees,
81.9% were in a monogamous relationship, 10.8% were
single while 0.3% were widowed.
HIV seroprevalence
A total of 309 (6.7%) ANC attendees were HIV seroposi-
tive in all the hospitals under study. Kitale had the highest
proportion (68.6%) followed by Kapsabet (18.1%) and
13.3% from South Nandi Hills. The HIV prevalence per
hospital was 15.3%, 3.4% and 2% for Kitale, Kapsabet
and Nandi hills respectively. Majority of the HIV seropos-
itive antenatal attendees did not know their HIV status
prior to visiting the clinic for antenatal care (85.1%), and
were not on anti-retroviral therapy (97.1%) (Table 2).
The age specific HIV prevalence among antenatal attend-
ees was analysed and is shown in Figure 1. The 31–35 age
group had the highest (8.5%) HIV prevalence, while
women aged more than 35 years had the lowest preva-
lence (2.5%). Widowed antenatal attendees had higher
(16.7%) HIV prevalence followed by polygamous,
monogamous and single with 14.1%, 5.3% and 4.1%
respectively (Figure 2).
The highest HIV prevalence (6.3%) was recorded among
antenatal attendees who had attended secondary schools
followed by those with primary and tertiary level of edu-
cation (6% and 5% respectively) (Figure 3). Table 3
presents the profiles of the pregnant women associated
with HIV infection. Women in a polygamous relationship
were more likely to be HIV infected as compared to those
in a monogamous relationship (p = 0.000). There was no
statistically significant association between HIV infection
and level of education.
Lymphocyte subset count
The CD4 count was available for 278 ANC attendees. The
mean CD4 count was 466 cells/mm3 (9–2000 cells/mm3).
The CD4 counts were further categorised into three groups
(<200, 200–349 and >350 cells per cubic millilitre) based
on the WHO CD4/disease staging categories. The majority
of the antenatal clinic attendees had >350 cells/mm3
(60.07%) followed by 200–349 cells/mm3  and <200
cells/mm3 with 25.9 and 14.03% respectively (Table 4).
Discussion
The HIV prevalence reported in this study is similar to ear-
lier reports in Kitale district hospital and other health
facilities used as sentinel surveillance sites for HIV and
STDs prevalence in Kenya [2,3]. In the current study, the
overall HIV prevalence was 6.7% with Kitale district hos-
pital having the highest (15.3%) followed by Kapsabet
and South Nandi Hills district hospitals (3.4% and 2%
respectively). In 2001, 2002, 2003 and 2004, the HIV
prevalence in Kitale district hospital was 13%, 16%, 11%
and 7% respectively among antenatal attendees [3]. The
disparities in HIV prevalence in the hospitals may be due
to differences in urbanization, ethnic groups and eco-
nomic activities in the specific areas but further studies are
required to elucidate the reasons in details.
The highest proportion of HIV infected women was in the
age group 21–25 years (35.5%). This peak age group dif-
fered from the report of a demographic health survey car-
ried out in 2003 where the peak was in 25–29 years (13%)
among women [2].
In this study, it was found that women in a polygamous
marriage had a higher HIV positivity than those in
monogamous union (p = 0.000). This suggests that polyg-
amy is a risk factor for HIV-1 infection. However, it should
be noted that marital status was self-reported and the




<21 years 1310 (28.5)
21–25 years 1598 (34.8)
26–30 years 990 (21.5)
31–35 years 445 (10.8)









Table 2: Characteristics of HIV seropositive pregnant women
Characteristics Category Number (N) Proportion (%)
HIV status known No 263 85.1
Yes 46 14.9
Used antiretroviral drugs No 299 97.1
Yes 9 2.9BMC International Health and Human Rights 2009, 9:10 http://www.biomedcentral.com/1472-698X/9/10
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HIV Prevalence by age group Figure 1
















































HIV Prevalence among antenatal attendees by marital status Figure 2
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study did not specifically request for information on mul-
tiple partners. Despite this limitation in our study, it has
clearly shown that there is a relationship between HIV sta-
tus and marital status. This finding is in agreement with
previous reports where susceptibility and vulnerability to
HIV/AIDS was attributed to marital and family status
[4,5].
In the current study, there was no statistical significance
between the level of education and HIV infection (p =
0.653 and p = 0.469 for secondary and tertiary education
respectively). This differed from previous reports where
higher levels of education were associated with a higher
HIV seroprevalence [6]. However, some serial cross-sec-
tional studies have found greater reductions in HIV prev-
alence among the more educated groups, especially in
cohorts of young adults [7,8]. These findings suggest that
there is a shift in the association between education level
and HIV infection.
Among the pregnant women whose CD4 count was deter-
mined, 39 (14%) had less than 200 cells per cubic millili-
tre. As per the current Ministry of Health guidelines on
ARV therapy, all these women (39) should be on antiret-
HIV Prevalence among antenatal attendees by level of education Figure 3







































Table 3: Profiles of antenatal attendees associated with HIV infection
Characteristics N (%) N (HIV Prevalence%) OR (95% CI) P-value
Age groups
<21 years 1310 (28.5) 64 (4.89) 1.0
21–25 years 1598 (34.8) 97 (6.09) 0.8 (0.56–1.1) 0.165
26–30 years 990 (21.5) 65 (6.57) 0.73 (0.51–1.0) 0.083
31–35 years 495 (10.8) 42 (8.49) 0.55 (0.37–0.89) 0.004
>35 years 202 (4.4) 5 (2.48) 2.02 (0.81–5.1) 0.127
Type of marriage
Monogamous 3713 (91.7) 196 (5.28) 1.0
Polygamous 334 (8.3) 47 (14.07) 0.34 (0.24–0.48) 0.000
Educational status
Primary 3157 (69.4) 188 (5.96) 1.0
Secondary 1219 (26.8) 77 (6.32) 0.94 (0.71–1.24) 0.653
Tertiary 173 (3.8) 8 (4.62) 1.31 (0.63–2.96) 0.469BMC International Health and Human Rights 2009, 9:10 http://www.biomedcentral.com/1472-698X/9/10
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roviral treatment [9]. However, this study has established
that nine of these women are on ARVs, suggesting that
there are still major challenges in access of ARVs for those
who need them. Such a population would therefore be
missing the benefits of timely introduction of HAART,
such as the reported threefold reduction of AIDS inci-
dence when HAART is administered to patients with CD4
cell counts below 200 cells/mm3 [10].
It is important to critically evaluate the results and the
whole study. The present study has certain limitations that
need to be taken into account. The first major limitation
is that it was part of a larger study looking into drug resist-
ant HIV genotypes and their effect on prophylaxis against
HIV vertical transmission. In this regard, there are other
socioeconomic factors such as acres of land owned,
number of animals and cultivated farmlands that were
not include in the current study. The intricate relationship
between poverty and HIV has been shown to be a vicious
cycle in response to HIV pandemic. While increasing pov-
erty levels fuel the spread of HIV, the pandemic itself exac-
erbates those levels in households and families with
people living with HIV/AIDS [11]. The limitations of this
study bring forth some fruitful and interesting possible
avenues for future research that might be needed in rela-
tion to the theme of the study.
Conclusion
Scaling up HIV prevention efforts is mandatory in order to
prevent the escalation of the HIV epidemic associated
with individuals not knowing their status. The enumera-
tion of lymphocyte subset count should be introduced as
a routine test in the antenatal clinic. This will ensure that
the HIV seropositive pregnant women can be put on
antiretroviral therapy (ART) at an appropriate time.
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Table 4: T-lymphocyte (CD4) count among antenatal attendees
CD4 (cells/mm3) Number (N) Proportion (%)
<200 39 14.03
200–349 72 25.90
>350 167 60.07
Total 278 100